Novo Nordisk A/S vs SMX Security Matters plc — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while SMX Security Matters plc trades at $20 (market cap $16.38M). The key difference: Novo Nordisk A/S is far larger — about 13463.4× SMX Security Matters plc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while SMX Security Matters plc pays none. Which is the better fit depends on your goals.
| NVO | SMX | |
|---|---|---|
Market Cap | $220.53B | $16.38M |
Sector | Health | Technology |
52-Week High | $71.70 | $295.56K |
52-Week Low | $35.29 | $12.87 |
Enterprise Value | $239.49B | $13.35M |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →